T1	CHEM 609 617	cuprofán
#1	AnnotatorNotes T1	C0056591; cuprammonium cellulose; Organic Chemical · Pharmacologic Substance
T2	DISO 54 60	anemia
#2	AnnotatorNotes T2	C0002871; Anemia; Disease or Syndrome
T3	PROC 81 93	hemodiálisis
#3	AnnotatorNotes T3	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T4	PROC 740 743	IST
#4	AnnotatorNotes T4	C1277709; transferrin saturation measurement; Laboratory Procedure
T5	CHEM 172 188	toxinas urémicas
#5	AnnotatorNotes T5	C0077872; uremia middle molecule toxins; Organic Chemical · Hazardous or Poisonous Substance (?)
T6	DISO 180 188	urémicas
#6	AnnotatorNotes T6	C0041948; Uremia; Disease or Syndrome
T7	DISO 257 270	inflamatorios
#7	AnnotatorNotes T7	C0021368; Inflammation; Pathologic Function
T8	CHEM 931 939	cuprofán
#8	AnnotatorNotes T8	C0056591; cuprammonium cellulose; Organic Chemical · Pharmacologic Substance
T9	CHEM 289 300	celulósicas
#9	AnnotatorNotes T9	C0007648; cellulose; Organic Chemical · Biologically Active Substance
T10	CHEM 40 44	AN69
#10	AnnotatorNotes T10	C0051802; AN-69; Organic Chemical · Biomedical or Dental Material
T11	DISO 444 450	anemia
#11	AnnotatorNotes T11	C0002871; Anemia; Disease or Syndrome
T12	DISO 468 495	Insuficiencia Renal Crónica
#12	AnnotatorNotes T12	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T13	PROC 511 523	hemodiálisis
#13	AnnotatorNotes T13	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T14	CHEM 126 130	AN69
#14	AnnotatorNotes T14	C0051802; AN-69; Organic Chemical · Biomedical or Dental Material
T15	CHEM 430 434	AN69
#15	AnnotatorNotes T15	C0051802; AN-69; Organic Chemical · Biomedical or Dental Material
T16	PROC 582 592	dializados
#16	AnnotatorNotes T16	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T17	DISO 709 715	anemia
#17	AnnotatorNotes T17	C0002871; Anemia; Disease or Syndrome
T18	CHEM 866 870	AN69
#18	AnnotatorNotes T18	C0051802; AN-69; Organic Chemical · Biomedical or Dental Material
T19	PROC 839 849	dializarse
#19	AnnotatorNotes T19	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T20	PROC 1022 1025	IST
#20	AnnotatorNotes T20	C1277709; transferrin saturation measurement; Laboratory Procedure
T21	CONC 1031 1034	KTV
T22	PROC 944 955	seguimiento
#21	AnnotatorNotes T22	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T23	PROC 986 997	hematocrito
#22	AnnotatorNotes T23	C0018935; Hematocrit procedure; Laboratory Procedure
T24	PROC 1345 1348	IST
#23	AnnotatorNotes T24	C1277709; transferrin saturation measurement; Laboratory Procedure
T25	PROC 1126 1137	hematocrito
#24	AnnotatorNotes T25	C0018935; Hematocrit procedure; Laboratory Procedure
T26	PROC 1176 1187	hematocrito
#25	AnnotatorNotes T26	C0018935; Hematocrit procedure; Laboratory Procedure
T27	PROC 1251 1262	tratamiento
#26	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	CHEM 1298 1301	EPO
#27	AnnotatorNotes T28	C0014822; Erythropoietin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T29	PROC 1449 1460	hematocrito
#28	AnnotatorNotes T29	C0018935; Hematocrit procedure; Laboratory Procedure
T30	CHEM 1546 1550	AN69
#29	AnnotatorNotes T30	C0051802; AN-69; Organic Chemical · Biomedical or Dental Material
T31	PROC 1562 1573	hematocrito
#30	AnnotatorNotes T31	C0018935; Hematocrit procedure; Laboratory Procedure
T32	CHEM 1631 1645	Eritropoyetina
#31	AnnotatorNotes T32	C0014822; Erythropoietin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T33	ANAT 482 487	Renal
#32	AnnotatorNotes T33	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T34	PROC 525 527	HD
#33	AnnotatorNotes T34	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T35	PROC 578 580	HD
#34	AnnotatorNotes T35	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T36	PROC 717 726	ferritina
#35	AnnotatorNotes T36	C0373607; Ferritin measurement; Laboratory Procedure
T37	PROC 1003 1012	ferritina
#36	AnnotatorNotes T37	C0373607; Ferritin measurement; Laboratory Procedure
T38	CONC 1036 1039	PCR
#37	AnnotatorNotes T38	[Protein catabolic rate]
T39	CHEM 1062 1065	EPO
#38	AnnotatorNotes T39	C0014822; Erythropoietin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T40	PROC 1320 1328	diálisis
#39	AnnotatorNotes T40	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T41	PROC 1333 1342	ferritina
#40	AnnotatorNotes T41	C0373607; Ferritin measurement; Laboratory Procedure
T42	LIVB 68 77	pacientes
#41	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T44	PHYS 362 375	eritropoyesis
#42	AnnotatorNotes T44	C0014819; Erythropoiesis; Organ or Tissue Function
T45	LIVB 454 463	pacientes
#43	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	Duration 488 495	Crónica
#44	AnnotatorNotes T46	C0205191; chronic; Temporal Concept
T47	LIVB 565 574	pacientes
#45	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	Duration 626 646	un mínimo de 6 meses
T50	LIVB 794 803	pacientes
#46	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	Duration 963 970	5 meses
T54	Frequency 1069 1076	/semana
T55	Frequency 1078 1085	mensual
T56	Duration 1100 1114	2, 4 y 5 meses
T57	Duration 1241 1247	2º mes
T62	Duration 1469 1480	los 5 meses
T65	DEVI 27 36	membranas
#47	AnnotatorNotes T65	C4047366; Hemodialysis membrane; Medical Device
T66	DEVI 113 122	membranas
#48	AnnotatorNotes T66	C4047366; Hemodialysis membrane; Medical Device
T43	DEVI 279 288	membranas
#49	AnnotatorNotes T43	C4047366; Hemodialysis membrane; Medical Device
T67	DEVI 417 426	membranas
#50	AnnotatorNotes T67	C4047366; Hemodialysis membrane; Medical Device
T68	DEVI 597 605	membrana
#51	AnnotatorNotes T68	C4047366; Hemodialysis membrane; Medical Device
T49	DEVI 854 862	membrana
#52	AnnotatorNotes T49	C4047366; Hemodialysis membrane; Medical Device
T69	DEVI 922 930	membrana
#53	AnnotatorNotes T69	C4047366; Hemodialysis membrane; Medical Device
T53	DEVI 1533 1542	membranas
#54	AnnotatorNotes T53	C4047366; Hemodialysis membrane; Medical Device
T52	Neg_cue 1264 1267	sin
T58	PROC 1268 1294	modificaciones en la dosis
#55	AnnotatorNotes T58	C2064702; modify drug dosage; Health Care Activity
T59	PROC 1601 1627	modificaciones en la dosis
#56	AnnotatorNotes T59	C2064702; modify drug dosage; Health Care Activity
T60	Neg_cue 1597 1600	sin
T61	PHYS 156 168	aclaramiento
#57	AnnotatorNotes T61	C0232813; Renal clearance function; Organ or Tissue Function
A1	Assertion T58 Negated
A2	Assertion T59 Negated
T63	Observation 1 19	Efecto beneficioso
R1	Used_for Arg1:T10 Arg2:T65	
R2	Causes Arg1:T65 Arg2:T63	
R3	Experiences Arg1:T42 Arg2:T2	
R4	Experiences Arg1:T42 Arg2:T3	
R6	Experiences Arg1:T42 Arg2:T63	
R7	Used_for Arg1:T14 Arg2:T66	
R8	Causes Arg1:T66 Arg2:T70	
T64	Observation 145 188	aumenta el aclaramiento de toxinas urémicas
T70	Observation 232 270	activación de mediadores inflamatorios
R9	Used_for Arg1:T9 Arg2:T43	
R10	Causes Arg1:T66 Arg2:T64	
T71	Observation 334 352	efecto beneficioso
R11	Before Arg1:T66 Arg2:T71	
R12	Used_for Arg1:T15 Arg2:T67	
R13	Experiences Arg1:T45 Arg2:T11	
R14	Overlap Arg1:T11 Arg2:T12	
R15	Experiences Arg1:T45 Arg2:T12	
R16	Location_of Arg1:T33 Arg2:T12	
R17	Has_Duration_or_Interval Arg1:T12 Arg2:T46	
R18	Experiences Arg1:T45 Arg2:T13	
R19	Experiences Arg1:T45 Arg2:T34	
R22	Experiences Arg1:T47 Arg2:T35	
R23	Experiences Arg1:T47 Arg2:T16	
R24	Used_for Arg1:T68 Arg2:T16	
R25	Used_for Arg1:T68 Arg2:T35	
R26	Used_for Arg1:T1 Arg2:T68	
R27	Has_Duration_or_Interval Arg1:T16 Arg2:T48	
R28	Has_Duration_or_Interval Arg1:T35 Arg2:T48	
T72	Observation 651 668	situación estable
#58	AnnotatorNotes T72	C1282982; Patient's condition stable; Finding
R29	Experiences Arg1:T47 Arg2:T72	
T73	Result_or_Value 727 738	> 200 ng/ml
R30	Has_Result_or_Value Arg1:T36 Arg2:T73	
T74	Result_or_Value 744 749	> 20%
R31	Has_Result_or_Value Arg1:T4 Arg2:T74	
R32	Experiences Arg1:T47 Arg2:T17	
R33	Experiences Arg1:T47 Arg2:T36	
R34	Experiences Arg1:T47 Arg2:T4	
R37	Overlap Arg1:T72 Arg2:T17	
R38	Experiences Arg1:T50 Arg2:T19	
R39	Used_for Arg1:T49 Arg2:T19	
R40	Used_for Arg1:T18 Arg2:T49	
R41	Used_for Arg1:T69 Arg2:T19	
R42	Used_for Arg1:T8 Arg2:T69	
R43	Has_Duration_or_Interval Arg1:T22 Arg2:T51	
R44	Has_Frequency Arg1:T39 Arg2:T54	
R45	Has_Frequency Arg1:T39 Arg2:T55	
T75	Quantifier_or_Qualifier 1094 1099	Basal
#59	AnnotatorNotes T75	C1442488; Baseline; Quantitative Concept
R46	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T75	
R47	Has_Duration_or_Interval Arg1:T39 Arg2:T56	
T76	Observation 1176 1187;1197 1204	hematocrito aumentó
#60	AnnotatorNotes T76	C0239935; Hematocrit increased; Finding
R48	Overlap Arg1:T76 Arg2:T57	
R49	Before Arg1:T27 Arg2:T76	
R50	Negation Arg1:T52 Arg2:T58	
R51	Used_for Arg1:T28 Arg2:T58	
R52	Overlap Arg1:T58 Arg2:T40	
T77	Neg_cue 1431 1433	no
R55	Used_for Arg1:T30 Arg2:T53	
T78	Observation 1551 1573	aumenta el hematocrito
#61	AnnotatorNotes T78	C0239935; Hematocrit increased; Finding
R56	Causes Arg1:T53 Arg2:T78	
R57	Negation Arg1:T60 Arg2:T59	
R58	Used_for Arg1:T32 Arg2:T59	
R59	Overlap Arg1:T53 Arg2:T59	
R60	Overlap Arg1:T27 Arg2:T58	
T79	Observation 1434 1460	se modificó el hematocrito
A3	Assertion T79 Negated
R61	Negation Arg1:T77 Arg2:T79	
T80	Observation 1333 1342;1349 1361	ferritina disminuyeron
#62	AnnotatorNotes T80	C0241012; Decreased circulating ferritin concentration; Finding
T81	Observation 1345 1361	IST disminuyeron
#63	AnnotatorNotes T81	C0919785; Decreased transferrin saturation; Finding
R62	Overlap Arg1:T23 Arg2:T56	
R63	Overlap Arg1:T37 Arg2:T56	
R64	Overlap Arg1:T20 Arg2:T56	
R65	Overlap Arg1:T21 Arg2:T56	
R66	Overlap Arg1:T38 Arg2:T56	
R67	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T75	
R68	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T75	
R69	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T75	
R70	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T75	
R71	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T75	
R72	Has_Frequency Arg1:T23 Arg2:T55	
R73	Has_Frequency Arg1:T37 Arg2:T55	
R74	Has_Frequency Arg1:T20 Arg2:T55	
R75	Has_Frequency Arg1:T21 Arg2:T55	
R76	Has_Frequency Arg1:T38 Arg2:T55	
R77	Has_Duration_or_Interval Arg1:T79 Arg2:T62	
T82	Spec_cue 317 324	podrían
A4	Assertion T71 Speculated
R78	Speculation Arg1:T82 Arg2:T71	
T83	Neg_cue 681 692	se descartó
T84	Observation 693 705	otras causas
A5	Assertion T84 Negated
#64	AnnotatorNotes T84	C5555349; Other Disease Etiology; Finding
R79	Negation Arg1:T83 Arg2:T84	
#65	AnnotatorNotes T71	C4049461; Unexpected beneficial therapeutic response; Finding (?)
#66	AnnotatorNotes T63	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R80	Causes Arg1:T84 Arg2:T17	
#67	AnnotatorNotes T79	C0744726; HEMATOCRIT CHANGE; Finding
A6	Experiencer T42 Patient
A7	Experiencer T45 Patient
A8	Experiencer T47 Patient
A9	Experiencer T50 Patient
R5	Has_Result_or_Value Arg1:T26 Arg2:T76	
R20	Has_Result_or_Value Arg1:T41 Arg2:T80	
R21	Has_Result_or_Value Arg1:T24 Arg2:T81	
R35	Has_Result_or_Value Arg1:T29 Arg2:T79	
R36	Has_Result_or_Value Arg1:T31 Arg2:T78	
